Warning letter
Creative Medical Corporation: warning letter of May 5, 2006
FDA warning letter UCM238151 · San Juan District Office
Key facts
| Reference number | UCM238151 |
|---|---|
| Company | Creative Medical Corporation |
| Subject | OTC Drug Products/Dietary Supplements/Misbranded |
| Issue date | May 5, 2006 |
| Posted date | May 5, 2006 |
| Issuing office | San Juan District Office |
| Product type | Drugs |
| CFR sections cited | 341.72(c)(3), 341.85(b)(5), 341.80(c)(1), 73.340, 101.22(j), 101.22(k)(1), 101.36(b)(2), 101.36(d), 328.50, 341, 341.18, 341.20 and 7 more |
| Country | 3 |
| Inspection city | Cidra |
| Inspection ZIP | 00739 |
| Inspection start date | Oct 31, 2005 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: